<?xml version="1.0" encoding="UTF-8"?>
<ref id="B137-pharmaceuticals-13-00096">
 <label>137.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Simmons</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Zmora</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Gierer</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Heurich</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Pohlmann</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research</article-title>
  <source>Antivir. Res.</source>
  <year>2013</year>
  <volume>100</volume>
  <fpage>605</fpage>
  <lpage>614</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2013.09.028</pub-id>
  <pub-id pub-id-type="pmid">24121034</pub-id>
 </element-citation>
</ref>
